Heartland Financial Chief Investment Officer Nancy Tengler tells CNBC's Power Lunch on Tuesday she believes the sector is oversold.
"Overall we expect that when the political rhetoric subsides investors and politicians will once again recall that pharmaceutical innovation not only saves lives but lowers overall health care costs," Tengler said.
She has been adding to health care on dips and one of her top picks is medical device maker Medtronic.
Tengler also sees opportunities outside of health care.
Medtronic is lower during trading, while Harris is higher.